Hematologic Malignancy
B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like
CI-CAN-00004540Explore in graph →
Hematologic3 active trials80 evidence items
- NCIt
- C129787
- OncoTree
- BLLBCRABL1L
- DOID
- 0080650
- UMLS CUI
- C4329382
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00004540Explore in graph →
Research activity
Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.
| Window | Period | Records (count) | Exact query | Computed | Source |
|---|---|---|---|---|---|
| All time | … → 2026-09-30 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) | 2026-09-30 | pubmed |
| Last 5 years | 2021-01-01 → 2026-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2021/01/01:2026/12/31[dp]) | 2026-09-30 | pubmed |
| Preceding 5-year window | 2020-09-30 → 2025-09-29 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2020/09/30:2025/09/29[dp]) | 2026-09-30 | pubmed |
| Last 12 months | 2025-09-30 → 2026-09-30 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2025/09/30:2026/09/30[dp]) | 2026-09-30 | pubmed |
| y2016 | 2016-01-01 → 2016-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2016/01/01:2016/12/31[dp]) | 2026-09-30 | pubmed |
| y2017 | 2017-01-01 → 2017-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2017/01/01:2017/12/31[dp]) | 2026-09-30 | pubmed |
| y2018 | 2018-01-01 → 2018-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2018/01/01:2018/12/31[dp]) | 2026-09-30 | pubmed |
| y2019 | 2019-01-01 → 2019-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2019/01/01:2019/12/31[dp]) | 2026-09-30 | pubmed |
| y2020 | 2020-01-01 → 2020-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2020/01/01:2020/12/31[dp]) | 2026-09-30 | pubmed |
| y2021 | 2021-01-01 → 2021-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2021/01/01:2021/12/31[dp]) | 2026-09-30 | pubmed |
| y2022 | 2022-01-01 → 2022-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2022/01/01:2022/12/31[dp]) | 2026-09-30 | pubmed |
| y2023 | 2023-01-01 → 2023-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2023/01/01:2023/12/31[dp]) | 2026-09-30 | pubmed |
| y2024 | 2024-01-01 → 2024-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2024/01/01:2024/12/31[dp]) | 2026-09-30 | pubmed |
| y2025 | 2025-01-01 → 2025-12-31 | 0 | ("B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features"[tiab] OR "B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors"[tiab]) AND (2025/01/01:2025/12/31[dp]) | 2026-09-30 | pubmed |
Data updated 12 hours agoSource updated unknownsource: pubmed E-utilities
Literature
Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.
· Cancer Cell · 2012 · PMID 22897847 · validated civic_curation pubmed
· Mod Pathol · 2014 · PMID 24030742 · validated civic_curation pubmed
· Cancer Cell · 2016 · PMID 26859458 · validated civic_curation pubmed
· Blood · 2017 · PMID 28408464 · validated civic_curation pubmed
· Pediatr Blood Cancer · 2024 · PMID 38302862 · validated civic_curation pubmed
· Ann Diagn Pathol · 2020 · PMID 32330662 · validated civic_curation pubmed
· Haematologica · 2021 · PMID 34196168 · validated civic_curation pubmed
· Cancer Gene Ther · 2022 · PMID 35022522 · validated civic_curation pubmed
· J Clin Oncol · 2013 · PMID 23835704 · validated civic_curation pubmed
· Haematologica · 2018 · PMID 29773603 · validated civic_curation pubmed
· J Clin Oncol · 2017 · PMID 27870571 · validated civic_curation pubmed
· EBioMedicine · 2016 · PMID 27428428 · validated civic_curation pubmed
· Blood Cancer J · 2016 · PMID 27176795 · validated civic_curation pubmed
· J Pediatr Hematol Oncol · 2021 · PMID 32068648 · validated civic_curation pubmed
· Acta Haematol · 2017 · PMID 27894117 · validated civic_curation pubmed
· Blood · 2019 · PMID 31434701 · validated civic_curation pubmed
· Front Oncol · 2020 · PMID 32266142 · validated civic_curation pubmed
· Haematologica · 2016 · PMID 26681761 · validated civic_curation pubmed
· Br J Haematol · 2011 · PMID 21391972 · validated civic_curation pubmed
· Br J Haematol · 2015 · PMID 26404892 · validated civic_curation pubmed
· Leuk Lymphoma · 2017 · PMID 27855558 · validated civic_curation pubmed